Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025. The company also raised its FY25 guidance to reflect a stronger business outlook for the year.
Total revenue rose 7% year-over-year to $2.65 billion in the June quarter. For the full year of 2025, the company expects revenues to be broadly flat, at constant currency, versus full year 2024, which is up from a mid-single digit decline it forecast previously.
Net income attributable to Biogen was $634.8 million or $4.33 per share in Q2, compared to $583.6 million or $4.0 per share in the second quarter of 2024. Adjusted earnings increased 4% annually to $5.47 per share in the second quarter.
The management raised its full-year adjusted earnings per share guidance to the range of $15.50 to $16.00 from the earlier outlook of $14.50-15.50.
Biogen’s CEO. Christopher Viehbacher said, “We delivered another quarter of strong execution against our strategy to transform our portfolio and build the new Biogen. Our performance reflects robust financial results, ongoing cost discipline, continued growth of our launch products, and meaningful strides in expanding and advancing our late-stage pipeline.“
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
